{"Clinical Trial ID": "NCT00784849", "Intervention": ["INTERVENTION 1:", "Biopsy of lymph nodes with radiolabelled methylene blue", "One diagnostic arm using 1 mCi blue dye Methylene 125-I to find sentinel lymph nodes"], "Eligibility": ["Incorporation criteria:", "Stage 0,I,II breast cancer", "Clinical status N0, N1", "No allergy to iodine, lymphazurine or methylene blue dyes", "- Exclusion criteria:", "A patient cannot be pregnant or breast-feeding", "Inmates will not be eligible.", "Women under 18 years of age will not be eligible", "Patients with known allergy to iodine or to blue methylene or blue lymphazurine dyes"], "Results": ["Performance measures:", "The number of participants who have sentinel nodes that are radioactive or blue, or radioactive and blue, or who have efferent blue lymphatics leading to the sentinel knot(s)", "[Unspecified]", "Duration: intraoperative; up to 6 hours", "Results 1:", "Title of the arm/group: Biopsy of lymph nodes with radiolabelled methylene blue", "Description of the arm/group: Diagnosis of an arm using 1 mCi blue dye Methylene 125-I to find sentinel lymph nodes", "Total number of participants analysed: 62", "Type of measurement: Number", "Unit of measure: participants Radioactive: 58", "Blue: 55", "Radioactive and blue: 55", "- Blue lymphatic efferent leading to the NSA: 0"], "Adverse Events": ["Undesirable Events 1:", "Total: 0.62 (0.00 per cent)"]}